| Literature DB >> 35280569 |
Khalid Al-Khaldi1,2, Nurhusien Yimer1, Mohammed B Sadiq3, Faez Firdaus Jesse Bin Abdullah1, Abdul Salam Babji4, Samir Al-Bulushi5.
Abstract
Diluents and various biological products have been used in different animal species, with promising outcomes in post-thaw sperm quality. Nevertheless, only a few reports are available for the semen of Arabian horses. Edible bird's nest (EBN) - a product of the salivary secretions of swiftlet species is widely known to have both antioxidant and anti-inflammatory properties. Presently, there is no data available on the role of EBN supplemented in different extenders and its effect on semen quality in stallion semen. Two in vitro experiments were conducted to examine the effects of edible bird's nest (EBN) on the quality of chilled and post-thawed cryopreserved Arabian stallion spermatozoa. In experiment one, 10 ejaculates were collected, divided into two equal parts, diluted using EquiPlus® and INRA 96® and supplemented with 0 % (control), 0.12 %, 0.24 % EBN concentrations. The semen samples were stored at 5 ℃ and observed at 0, 24, and 48 h. Sperm kinetics variables (% total motility [TM] and progressive motility [PM], curvilinear velocity; VCL, straightness; VSL, average path velocity; VAP) were analyzed using computerized assisted sperm analysis. For chilled semen, there was no significant difference in any of the sperm quality parameters between control (0 %), 0.12 %, and 0.24 % EBN supplementation either in INRA96® or EquiPlus®. In experiment two, nine ejaculates were diluted and cryopreserved using EquiPlus Freeze® and INRA Freeze® containing 0 %, 2.4 %, and 4.8 % EBN, and evaluated after thawing. Sperm kinetics, DNA integrity and antioxidant capacity - Biological Anti-oxidant Potential (BAP) and Reactive Oxygen Metabolites (d-ROMs) test were evaluated. In chilled semen, there was no significant difference in any of the sperm quality parameters between control (0 %), 0.12 %, and 0.24 % EBN supplementation either in INRA96® or EquiPlus®. For frozen semen supplemented with 2.4 % and 4.8 % EBN had higher sperm motility parameters compared to control in INRA Freeze® and EquiPlus Freeze®, but the values were not statistically significant (P > 0.05). Also, EBN supplementation had no significant effects on the DNA integrity, biological antioxidant potential, and reactive oxygen metabolites. EBN supplementation had no significant effects on sperm quality and antioxidant status in chilled and frozen Arabian Stallion semen. Future studies might consider different methods of EBN preparation and concentrations to elucidate the potential biological impact of EBN in Arabian stallion semen.Entities:
Keywords: AS, Arabian Stallion; Antioxidant; Arabian stallion; BAP, Biological Anti-Oxidant Protection; Cryopreserved Semen; DNA, Deoxyribonucleic Acid; EBN, Edible Bird Nest; Edible Bird’s Nest; EquiPlus®; INRA®; ROS, Reactive oxygen species; d-ROMs, Determination of Reactive Oxygen Metabolites
Year: 2021 PMID: 35280569 PMCID: PMC8913401 DOI: 10.1016/j.sjbs.2021.11.009
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Semen extenders used for chilled and frozen stallion semen in the present study.
| Components | Manufacturer | |
|---|---|---|
| Extender for chilled semen | ||
| INRA 96® | Purified fractions of the milk micellar protein, penicillin, gentamicin, and amphotericin B. | IMV technologies, France |
| EquiPlus® | Caseinates derived from various fractions of milk casein, lincomycin and spectinomycin. | Minitub, Tiefenbach, Germany |
| Extender for frozen semen | ||
| INRA Freeze® | Purified fractions of the milk micellar protein, sterilized egg yolk plasma (2%), Sugars, Salts, Buffer, penicillin, gentamicin, and amphotericin B, Glycerol (2.5%). | IMV technologies, France |
| EquiPlus Freeze® | Skim milk, Sugars, Buffer, Gentamicin sulfate Glycerol (3%) | Minitub, Tiefenbach, Germany |
Composition of bioactive edible bird’s nests (EBN) hydro-peptides analyzed in UKM UNIPEQ.
| Parameter, Unit | Result | Test Method |
|---|---|---|
| Sialic Acid, % | 16.4 | HPLC |
| Protein, g/100 g | 64 | Method No. STP/Chem/A03 based on AOAC 16th Edi. 981.10 |
| Total Fat, g/100 g | 0.6 | Method No. STP/Chem/A02(ii) based on the Chemical Analysis of Food, David Pearson, 6th Edition: Page13 |
| Total Carbohydrate, g/100 g | 26.6 | Method No. STP/Chem/A06 based on Promerance Food Analysis: Theory and Practice, 2nd Ed. (pg 637) |
| Total Ash, g/100 g | 2.2 | Method No. STP/Chem/A05 based on AOAC 16th Edi. 923.03 |
| Moisture, g/100 g | 6.6 | Method No. STP/Chem/A04 based on AOAC 16th Edi. 950.46 |
| Energy, kcal/100 g | 368 (1546 kJ) | Method No. STP/Chem/A03 based on Person’s The Chemical Analysis of Foods (6th Edition, page 578) |
Settings of the Hamilton Thorne CEROS animal software (Version 12) used to assess stallion sperm kinematics.
| Variable | Setting |
|---|---|
| Frame rate | 60 Hz |
| Number of frames required | 45 |
| Minimum contrast | 55 |
| Minimum cell size (pixels) | 6 |
| Progressive path velocity cut-off | 30 μm/s |
| Progressive straightness | 60% |
| Slow average path velocity cutoff | 10 μm/s |
| Slow straight-line velocity cutoff | 5 μm/s |
| Static average path velocity cutoff | 4 μm/s |
| Static average line velocity cutoff | 1 μm/s |
| Non-motile head size (pixels) | 0.5–4.8 |
| Non-motile head intensity | 0.25–1.8 |
| Non-motile head intensity | 1.87 x |
| Video frequency | 60 |
| Illumination intensity | 2300 |
| Temperature | 37 °C |
Effects of supplementation of semen extender with EBN on the sperm kinetics and viability of chilled Arabian stallion spermatozoa.
| INRA 96® | EquiPlus® | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | |||||||||
| Total motility (%) | 0 | 96.2 ± 1.7 | 96.8 ± 1.8 | 92.8 ± 2.7 | 95.7 ± 1.5 | 96.4 ± 0.8 | 94.7 ± 1.1 | ||
| 24 | 83.0 ± 6.4 | 79.2 ± 8.6 | 84.2 ± 6.2 | 67.5 ± 7.8 | 67.0 ± 7.5 | 70.1 ± 8.1 | |||
| 48 | 63.4 ± 16.5 | 62.8 ± 15.6 | 68.2 ± 13.3 | 34.5 ± 7.9 | 29.5 ± 9.3 | 38.0 ± 12.4 | |||
| Progressive motility (%) | 0 | 54.0 ± 7.0 | 55.0 ± 6.4 | 49.1 ± 6.1 | 55.1 ± 2.1 | 58.2 ± 1.8 | 54.8 ± 2.7 | ||
| 24 | 38.0 ± 5.1 | 36.7 ± 5.7 | 38.8 ± 4.9 | 20.7 ± 4.2 | 23.2 ± 4.6 | 28.0 ± 2.0 | |||
| 48 | 21.0 ± 6.8 | 21.4 ± 6.5 | 24.6 ± 5.83 | 6.8 ± 2.2 | 5.5 ± 2.1 | 8.7 ± 3.3 | |||
| Path Velocity (VAP, µm/s) | 0 | 159.2 ± 23.5 | 165.1 ± 26.1 | 158.9 ± 19.3 | 161.5 ± 5.8 | 172.9 ± 4.6 | 161.0 ± 6.4 | ||
| 24 | 130.2 ± 9.4 | 132.9 ± 11.9 | 132.5 ± 9.6 | 81.5 ± 4.8 | 88.6 ± 8.4 | 93.8 ± 10.0 | |||
| 48 | 87.1 ± 11.7 | 98.0 ± 7.2 | 99.4 ± 4.0 | 64.7 ± 1.6 | 58.6 ± 1.7 | 60.7 ± 3.7 | |||
| Progressive velocity (VSL, µm/s) | 0 | 127.1 ± 20.3 | 131.4 ± 22.5 | 126.2 ± 16.7 | 126.7 ± 5.8 | 136.5 ± 3.7 | 126.9 ± 5.9 | ||
| 24 | 101.4 ± 8.0 | 105.2 ± 10.6 | 104.1 ± 9.4 | 59.2 ± 4.4 | 64.8 ± 7.8 | 70.3 ± 9.0 | |||
| 48 | 64.2 ± 9.7 | 73.4 ± 5.6 | 73.8 ± 4.1 | 40.4 ± 2.3 | 38.3 ± 1.0 | 38.7 ± 3.7 | |||
| Curvilinear velocity (VCL, µm/s) | 0 | 257.7 ± 41.3 | 263.2 ± 45.5 | 255.0.8 ± 32.8 | 259.6 ± 13.9 | 288.5 ± 8.5 | 260.5 ± 16.7 | ||
| 24 | 224.7 ± 14.0 | 227.8 ± 19.3 | 226.1 ± 14.9 | 142.1 ± 7.6 | 153.8 ± 13.5 | 161.5 ± 16.5 | |||
| 48 | 161.0 ± 21.4 | 174.4 ± 12.2 | 177.5 ± 16.8 | 110.4 ± 6.5 | 107.4 ± 3.1 | 108.7 ± 6.1 | |||
| Lateral head amplitude (ALH, µm) | 0 | 8.6 ± 1.3 | 8.3 ± 1.3 | 8.9 ± 1.0 | 9.4 ± 0.4 | 9.8 ± 0.5 | 9.6 ± 0.5 | ||
| 24 | 8.8 ± 0.4 | 8.9 ± 0.3 | 8.5 ± 0.3 | 6.4 ± 0.2 | 6.6 ± 0.4 | 6.7 ± 0.4 | |||
| 48 | 7.3 ± 0.8 | 8.0 ± 0.4 | 7.8 ± 0.4 | 6.0 ± 0.4 | 5.7 ± 0.2 | 5.3 ± 0.1 | |||
| Beat cross frequency (BCF, Hz) | 0 | 13.1 ± 2.5 | 13.9 ± 2.2 | 13.4 ± 1.9 | 21.7 ± 3.0 | 20.5 ± 2.9 | 22.0 ± 2.9 | ||
| 24 | 16.1 ± 1.3 | 17.0 ± 1.5 | 16.1 ± 1.3 | 14.2 ± 0.8 | 13.9 ± 1.1 | 14.2 ± 1.1 | |||
| 48 | 11.2 ± 2.3 | 15.4 ± 1.2 | 14.8 ± 1.6 | 14.7 ± 0.9 | 15.0 ± 2.2 | 14.4 ± 2.4 | |||
| Straightness (STR, %) | 0 | 75.6 ± 1.6 | 76.6 ± 2.1 | 75.6 ± 1.3 | 74.5 ± 2.3 | 75.2 ± 2.1 | 74.3 ± 2.3 | ||
| 24 | 72.4 ± 1.3 | 73.1 ± 1.5 | 73.5 ± 1.7 | 57.7 ± 1.6 | 67.0 ± 1.9 | 69.0 ± 1.9 | |||
| 48 | 65.6 ± 1.8 | 70.0 ± 0.7 | 74.0 ± 3.9 | 62.7 ± 3.0 | 63.7 ± 2.5 | 63.7 ± 1.6 | |||
| Linearity (LIN, %) | 0 | 48.6 ± 1.6 | 50.2 ± 2.4 | 47.8 ± 1.6 | 44.7 ± 1.8 | 45.7 ± 1.5 | 44.7 ± 1.6 | ||
| 24 | 42.7 ± 1.2 | 43.3 ± 0.9 | 44.1 ± 1.2 | 40.5 ± 1.1 | 40.1 ± 1.1 | 41.7 ± 1.2 | |||
| 48 | 38.8 ± 0.5 | 40.8 ± 0.7 | 41.0 ± 1.4 | 38.0 ± 1.5 | 39.0 ± 2.6 | 38.5 ± 1.3 | |||
| Viable spermatozoa (%) | 0 | 75.8 ± 7.6 | 68.2 ± 8.7 | 67.4 ± 8.3 | 53.3 ± 8.3 | 59.3 ± 9.7 | 60.3 ± 8.3 | ||
| 24 | 50.2 ± 8.2 | 42.1 ± 6.0 | 49.1 ± 8.4 | 44.5 ± 9.0 | 35.7 ± 8.4 | 38.5 ± 5.3 | |||
| 48 | 36.6 ± 8.2 | 42.4 ± 10.9 | 36.4 ± 9.4 | 24.4 ± 12.4 | 25.2 ± 11.7 | 32.2 ± 14.3 | |||
Note: Comparisons are between groups of treatment across the rows for each extender and storage time. For all the variable assessed, no significant difference were found between supplemented and control groups.
Comparisons of frozen-thawed sperm kinetics processed with INRA Freez® and EquiPlus Freeze® extenders supplemented with EBN.
| Variables | ||||||
|---|---|---|---|---|---|---|
| Total motility (%) | 63.6 ± 8.5 | 56.1 ± 7.1 | 53.4 ± 8.6 | 44.2 ± 9.3 | 53.9 ± 6.6 | 50.5 ± 9.2 |
| Progressive motility (%) | 25.3 ± 3.5 | 19.6 ± 3.0 | 21.2 ± 3.4 | 13.6 ± 3.7 | 16.5 ± 3.7 | 16.3 ± 3.4 |
| Path Velocity (VAP, µm/s) | 99.1 ± 7.8 | 89.3 ± 4.8 | 97.1 ± 5.1 | 73.2 ± 4.5 | 74.4 ± 2.6 | 78.7 ± 4.2 |
| Progressive velocity (VSL, µm/s) | 77.5 ± 7.2 | 69.6 ± 4.3 | 76.8 ± 4.0 | 54.4 ± 3.7 | 56.2 ± 2.2 | 60.9 ± 3.4 |
| Curvilinear velocity (VCL, µm/s) | 170.1 ± 11.3 | 153.4 ± 7.1 | 165.0 ± 7.7 | 126.7 ± 8.2 | 129.9 ± 3 | 136.2 ± 6.8 |
| Lateral head amplitude (ALH, µm) | 7.2 ± 0.3 | 7.0 ± 0.2 | 7.3 ± 0.2 | 6.5 ± 0.3 | 6.3 ± 0.1 | 6.8 ± 0.2 |
| Beat cross frequency (BCF, Hz) | 14.9 ± 0.9 | 15.9 ± 1.2 | 16.0 ± 1.2 | 13.9 ± 1.4 | 14.7 ± 0.9 | 16.1 ± 1.2 |
| Straightness (STR, %) | 73.1 ± 1.4 | 72.6 ± 0.9 | 74.4 ± 1.2 | 69.7 ± 1.0 | 70.5 ± 1.1 | 72.0 ± 1.2 |
| Linearity (LIN, %) | 44.0 ± 1.6 | 43.7 ± 0.7 | 45.1 ± 0.8 | 42.7 ± 0.9 | 42.0 ± 1.1 | 42.7 ± 0.6 |
Note: Comparisons are across the rows between the various EBN concentrations for each extender. Means were not statistically different between control and EBN concentrations in both extenders.
Comparisons of sperm kinetics between INRA Freeze® and EquiPlus Freeze® following supplementation of frozen-thawed Arabian stallion semen with 0 %, 2.4 % and 4.8 % EBN.
| Variables | ||||||
|---|---|---|---|---|---|---|
| Total motility (%) | 92.7 ± 2.9 | 96.0 ± 1.5 | 94.8 ± 5.6 | 85.7 ± 6.7 | 92.0 ± 2.1 | 89.3 ± 3.4 |
| Progressive motility (%) | 59.4 ± 6.6 | 71.9 ± 4.3 | 67.8 ± 6.7 | 41.7 ± 4.4 | 40.7 ± 2.3 | 41.3 ± 3.4 |
| Path Velocity (VAP, µm/s) | 165.1 ± 10.1 | 173.6 ± 7.5 | 178.5 ± 8.3 | 131.3 ± 8.0 | 125.9 ± 4.5 | 128.7 ± 7.7 |
| Progressive velocity (VSL, µm/s) | 122.0 ± 8.2 | 129.6 ± 5.6 | 130.5 ± 5.5 | 99.2 ± 4.6 | 94.3 ± 1.9 | 96.3 ± 3.9 |
| Curvilinear velocity (VCL, µm/s) | 283.4 ± 14.8 | 292.7 ± 15.2 | 303.0 ± 16.9 | 225.0 ± 16.7 | 219.4 ± 11.3 | 221.5 ± 17.1 |
| Lateral head amplitude (ALH, µm) | 11.3 ± 0.6 | 11.2 ± 0.7 | 11.4 ± 0.7 | 9.0 ± 0.7 | 9.0 ± 0.7 | 8.9 ± 0.8 |
| Beat cross frequency (BCF, Hz) | 15.2 ± 3.7 | 14.3 ± 2.7 | 12.6 ± 2.8 | 18.2 ± 2.7 | 18.2 ± 3.3 | 18.2 ± 3.0 |
| Straightness (STR, %) | 69.0 ± 2.0 | 70.6 ± 2.1 | 69.7 ± 2.1 | 71.6 ± 2.2 | 69.5 ± 2.3 | 70.3 ± 2.1 |
| Linearity (LIN, %) | 40.6 ± 2.0 | 42.6 ± 1.9 | 41.6 ± 1.8 | 43.0 ± 1.9 | 40.8 ± 2.0 | 42.2 ± 1.7 |
Note: Comparisons are across the rows between the various EBN concentrations for each extender. Means were not statistically different between control and EBN concentrations in both extenders. Values within a column with different superscripts differ (P < 0.05).
Fig. 1Comparisons of the antioxidant properties and DNA integrity of frozen thawed Arabian stallion sperm processed with INRA Freeze® and EquiPlus Freeze® extenders supplemented with EBN. A = d-ROMS (Reactive oxygen metabolites), B = BAP (Biological antioxidative potential), C = DNA integrity. U CARR = Caratelli Units (1U CARR = 0.08 mg/100 ml H2O2). Note: Comparisons are between results (mean ± S.E) of the control and various EBN dose supplemented groups of the same extender. No significant difference (p > 0.05) were found for all the three variables (A, B, C) assessed.